Leap Therapeutics
(NASDAQ:LPTX)
$0.6046
0.0525[9.51%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$0.61
0.0054[0.89%]
After Hours: 4:16PM EDT
Day Range0.55 - 0.6152 Wk Range0.55 - 3.45Open / Close0.56 / 0.6Float / Outstanding80.1M / 99M
Vol / Avg.299.5K / 648KMkt Cap59.9MP/E-50d Avg. Price0.79
Div / Yield-Payout Ratio-Total Float80.1MEPS-0.13

Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary

Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.

Loading...
Day Range0.55 - 0.6152 Wk Range0.55 - 3.45Open / Close0.56 / 0.6Float / Outstanding80.1M / 99M
Vol / Avg.299.5K / 648KMkt Cap59.9MP/E-50d Avg. Price0.79
Div / Yield-Payout Ratio-Total Float80.1MEPS-0.13
InvestorsObserver - Aug 30, 2022, 3:03PM
Sector: Health Care.Industry: Biotechnology
Leap Therapeutics Inc is a biopharmaceutical company developing novel therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways and by harnessing the immune system to attack cancer cells. Its clinical stage program is DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1. DKK1 is a protein that regulates the Wnt signaling pathways and enables tumor cells to proliferate and spread, as well as suppresses the immune system from attacking the tumor. The company is studying DKN-01 in multiple ongoing clinical trials in patients with esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, or prostate cancer. Its other clinical studies include P100, P102, P204,and P205.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.120-0.130 -0.0100
REV0
Q2 2022Est.ActualSurprise
EPS-0.100-0.150 -0.0500
REV80.000K0-80.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Leap Therapeutics (LPTX) stock?

A

You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Leap Therapeutics's (LPTX) competitors?

Q

What is the target price for Leap Therapeutics (LPTX) stock?

A

The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Raymond James on Friday, November 11, 2022. The analyst firm set a price target for 2.50 expecting LPTX to rise to within 12 months (a possible 313.50% upside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Leap Therapeutics (LPTX)?

A

The stock price for Leap Therapeutics (NASDAQ: LPTX) is $0.6046 last updated November 30, 2022, 9:00 PM UTC.

Q

Does Leap Therapeutics (LPTX) pay a dividend?

A

There are no upcoming dividends for Leap Therapeutics.

Q

When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?

A

Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 14, 2022.

Q

Is Leap Therapeutics (LPTX) going to split?

A

There is no upcoming split for Leap Therapeutics.

Q

What sector and industry does Leap Therapeutics (LPTX) operate in?

A

Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.